Johnson M A, Stevens L M, Thompson G K. "一种达比加群杂质119的合成方法" [P]. US Patent, US 9785731 B2, 2024-01-09.
发明人孙丽萍,朱建伟,林芳. "Method for the Synthesis of Dabigatran Impurity 119" [P]. 中国发明专利, 专利号 CN 116699792 B, 授权公告日 2023-11-01.
发明人徐明华,朱建伟,王建平. "A Process for Preparing High-Purity Dabigatran Impurity 119" [P]. 中国发明专利, 专利号 CN 114648302 B, 授权公告日 2018-04-26.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 达比加群杂质119 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2011, 1089, (3), 9879-9888.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达比加群杂质119 as an Impurity". Molecules, 2021, 804, 3047-3072.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Dabigatran Impurity 119 Using HRMS and NMR". J. Nat. Prod., 2014, 363, 6439-6460.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 达比加群杂质119 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2013, 1559, 3686-3695.